BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 15750978)

  • 1. [A single centre study about the effects of HFR on anemia].
    Righetti M; Ferrario GM; Milani S; Serbelloni P; Sessa A
    G Ital Nefrol; 2004; 21 Suppl 30():S168-71. PubMed ID: 15750978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HFR vs HDF-ON line: plasmatic amino acids loss evaluation].
    Ragazzoni E; Carpani P; Agliata S; Ciranna G; Cusinato S; Albini M; Cavagnino A
    G Ital Nefrol; 2004; 21 Suppl 30():S85-90. PubMed ID: 15747313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On-line hemodiafiltration with endogenous reinfusion (HFR). Experience of a Centre].
    Ballabeni C; Maccario M; Ciurlino D; Martino S; Tentori F; Bigatti G; Bertoli SV
    G Ital Nefrol; 2004; 21 Suppl 30():S181-4. PubMed ID: 15750981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial.
    Panichi V; Manca-Rizza G; Paoletti S; Taccola D; Consani C; Filippi C; Mantuano E; Sidoti A; Grazi G; Antonelli A; Angelini D; Petrone I; Mura C; Tolaini P; Saloi F; Ghezzi PM; Barsotti G; Palla R
    Nephrol Dial Transplant; 2006 Mar; 21(3):756-62. PubMed ID: 16303780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of hemodiafiltration with on-line endogenous reinfusion (on-line HFR) on anemia: design of a European, open, randomised, multicentre trial. European Collaborative Study.
    J Nephrol; 2000; 13(1):34-42. PubMed ID: 10720212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; YĆ¼ksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The hemodiafiltration with endogenous reinfusion reduces the erythroid progenitor inhibition by uremic serum].
    Aucella F; Scalzulli RP; Vigilante M; Stallone C
    G Ital Nefrol; 2004; 21 Suppl 30():S128-32. PubMed ID: 15750970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch from bicarbonate hemodialysis to hemodiafiltration with online regeneration of the ultrafiltrate (HFR): effects on nutritional status, microinflammation, and beta-microglobulin.
    Bossola M; Muscaritoli M; Tazza L; Giungi S; Panocchia N; Rossi Fanelli F; Luciani G
    Artif Organs; 2005 Mar; 29(3):259-63. PubMed ID: 15725229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N; Osman-Malik Y; Frinak S; Besarab A
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute biocompatibility of hemodiafiltration with endogenous reinfusion (HFR)].
    Aucella F; Gesuete A; Sereni L; Netti S; Savastano AM; Querques M; Specchio A; De Min A; Avanzi C; Montemurno C; Grandone E; Cappucci F; Procaccini DA; Stallone C; Gesualdo L;
    G Ital Nefrol; 2004; 21 Suppl 30():S185-9. PubMed ID: 15750982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrapure dialysate improves iron utilization and erythropoietin response in chronic hemodialysis patients - a prospective cross-over study.
    Hsu PY; Lin CL; Yu CC; Chien CC; Hsiau TG; Sun TH; Huang LM; Yang CW
    J Nephrol; 2004; 17(5):693-700. PubMed ID: 15593037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodiafiltration with endogenous reinfusion with and without acetate-free dialysis solutions: effect on ESA requirement.
    Bolasco PG; Ghezzi PM; Serra A; Corazza L; Murtas S; Mascia M; Cossu M; Ferrara R; Cogoni G; Cadinu F; Casu D; Contu B; Passaghe M; Ghisu T; Ganadu M; Logias F
    Blood Purif; 2011; 31(4):235-42. PubMed ID: 21242676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B; Guastaferro P; Gironda A; Marano V; Morrongiello L; Cillo N; Zito B; Nigro F; Frieri A; Rubino R; Bellizzi V
    G Ital Nefrol; 2002; 19(5):552-9. PubMed ID: 12439845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On-line haemodiafiltration with sorbent-regenerated ultrafiltrate as replacement fluid: Beta2-microglobulin removal versus filtration fraction].
    Emiliani G; Briganti M; Montanari A; Isola E; Fusaroli M
    G Ital Nefrol; 2004; 21 Suppl 30():S80-4. PubMed ID: 15747312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bicarbonate balance in hemodiafiltration (HDF): a comparison between two infusion methods of on-line prepared solution].
    Sidoti A; Borracelli D; Biagioli M; Ghezzi PM
    G Ital Nefrol; 2004; 21 Suppl 30():S177-80. PubMed ID: 15750980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Two-chamber hemodiafiltration: comparison between exogenous reinfusion (PFD) and endogenous reinfusion (HFR)].
    Schelotto C; Santoni O; Nasini MG; Pietrucci A; Caviglia PM; Tirotta A; Repetto M; Carozzi S
    G Ital Nefrol; 2004; 21 Suppl 30():S111-6. PubMed ID: 15747292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels].
    Tuccillo S; Bellizzi V; Catapano F; Di Iorio B; Esposito L; Giannattasio P; Maione E; Mangiacapra S; Minutolo R; Zamboli P; Conte G; De Nicola L
    G Ital Nefrol; 2002; 19(4):439-45. PubMed ID: 12369047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodiafiltration with endogenous reinfusion (HFR): evolution of the method].
    Ghezzi PM
    G Ital Nefrol; 2005; 22 Suppl 31():S105-10. PubMed ID: 15786381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.